REQUEST A DEMO
Total
USD $0.00
Search more companies

M2M Med. Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Lessors of Real Estate | Research and Development in Biotechnology (except Nanobiotechnology) | All Other Miscellaneous Schools and Instruction | Ambulatory Health Care Services | Offices of Physicians | Offices of All Other Miscellaneous Health Practitioners | Outpatient Care Centers | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals
Full name: M2M Med. Sp. z o.o. Profile Updated: March 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

M2M Med. Sp. z o.o. is a company based in Poland, with its head office in Chorzow. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was established on January 22, 2019. In 2022, the company reported a net sales revenue increase of 376.95%. Its’ total assets recorded a growth of 14.22%.

Headquarters
Ul. Lwowska 34
Chorzow; Slaskie; Postal Code: 41-500

Contact Details: Purchase the M2M Med. Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the M2M Med. Sp. z o.o. report to view the information.
Registered Capital:
Purchase the M2M Med. Sp. z o.o. report to view the information.
Incorporation Date:
January 22, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
91%
Subsidiaries
M2M Badania Kliniczne Sp. z o.o. sp. k.
Company Performance
Financial values in the chart are available after M2M Med. Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
376.95%
Total operating revenue
106.89%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
14.22%
Total equity
11.52%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-22.32%
Quick Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?